| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $462K | +137.9% |
| SG&A Expense | $110K | -69.8% |
| Operating Income | -$644K | -2.2% |
| Interest Expense | $106K | -22.2% |
| Net Income | -$789K | -7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $420 | -86.3% |
| Current Assets | $420 | -86.3% |
| Total Assets | $420 | -86.3% |
| Current Liabilities | $1.3M | +3.2% |
| Total Liabilities | $1.5M | +16.1% |
| Stockholders' Equity | -$1.5M | -16.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69K | +34.3% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $66K | -9.0% |